The hypothesis that Tdp1 is responsible for the drug resistance of some types of cancer [13] is supported by a number of studies: Tdp1 knockout mice and human cell lines that have a mutation that reduces the activity of this enzyme are hypersensitive to camptothecins [8,14,15,16,17]. The gene discussed is TDP1; the disease is cancer.